Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors

Explore clinical trials studying Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.

631 public trials 195 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumors trial results

Recruiting

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

NCT07349537

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, CRC, +30 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • START Midwest Grand Rapids, Michigan, United States
View Trial Details
Recruiting

A Study of BG-C477 in Participants With Advanced Solid Tumors

NCT06596473

Conditions
Advanced Solid Tumors
Locations
  • City of Hope Phoenix Cancer Center Goodyear, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Yale University Yale Cancer Center New Haven, Connecticut, United States
View all 59 locations
View Trial Details
Recruiting

A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

NCT05067283

Conditions
Advanced Solid Tumors
Locations
  • Moffitt Cancer Center ( Site 0261) Tampa, Florida, United States
  • START Midwest ( Site 0267) Grand Rapids, Michigan, United States
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0260) Hackensack, New Jersey, United States
  • Laura and Isaac Perlmutter Cancer Center ( Site 0270) New York, United States
View all 75 locations
View Trial Details
Recruiting

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

NCT06657222

Conditions
Advanced Solid Tumors, Breast Diseases, Breast Neoplasms, +16 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • University of Miami Miami, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View all 20 locations
View Trial Details
Recruiting

A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.

NCT07356453

Conditions
Advanced Solid Tumors
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • START - Midwest Grand Rapids, Michigan, United States
  • Washington University St. Louis St Louis, Missouri, United States
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

NCT06818643

Conditions
Advanced Solid Tumors, Malignant Neoplasm, Neoplasms
Locations
  • The University of Alabama at Birmingham ( Site 1005) Birmingham, Alabama, United States
  • University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 1003) Miami, Florida, United States
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 1009) Hackensack, New Jersey, United States
  • NEXT Oncology ( Site 1010) Austin, Texas, United States
View all 49 locations
View Trial Details
Recruiting

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

NCT07360314

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Diseases, +29 more
Locations
  • Yale University - Yale University School of Medicine New Haven, Connecticut, United States
  • Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center Huntersville, North Carolina, United States
  • NEXT Houston Galveston, Texas, United States
  • NEXT Oncology - PARENT San Antonio, Texas, United States
View Trial Details

Related conditions